Water-Soluble Quantum Dots for Near-Infrared Bioimaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional semiconductor nanocrystals (quantum dots) for biological imaging are expensive to produce, toxic, and lack near-infrared emission capabilities, leading to interference from autofluorescence in tissue imaging and limited commercial viability.
Innovation Solution
Development of water-soluble, non-toxic quantum dots with a narrow bandwidth emission in the 600-1100 nm range, synthesized using a method involving a metal sulfide or selenide core and a different metal sulfide or selenide outer region, allowing for near-infrared emissions without toxic heavy metals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional quantum dots are used for biological imaging, then imaging capability is achieved, but toxicity occurs due to heavy metal elements
Solution Approach 1:
The patent changes the compositional parameters of quantum dots by replacing toxic heavy metals (Cd, Pb) with non-toxic metals (Zn, Cu, In, Ag) while maintaining the nanocrystal structure and optical properties. This substitution enables biological imaging applications without the harmful toxicity effects of conventional quantum dots.
Solution Approach 2:
The patent employs composite material structures consisting of non-toxic metal cores (Zn, Cu, In, Ag) combined with semiconductor compounds (sulfides, selenides, tellurides). These composite structures achieve the desired optical properties for imaging while eliminating toxic heavy metal content, resolving the contradiction between imaging capability and toxicity.
2Illumination intensity
If conventional quantum dots are used, then luminescence is achieved, but near-infrared emission is not obtained due to spectral overlap with autofluorescence
Solution Approach 1:
The patent adjusts the compositional parameters of quantum dots using specific non-toxic metal combinations (ZnCuInS, ZnAgInS, CuInS) and controls particle size (2-10 nm) to shift the emission spectrum into the near-infrared range (650-900 nm). This parameter optimization enables luminescence emission that avoids spectral overlap with tissue autofluorescence, eliminating imaging interference.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new quantum dots enable effective biological imaging and analyte detection with reduced autofluorescence interference, providing a safer and more commercially viable option for medical applications.
Implementation Method 1
reacting one or more water-soluble capping agents and a water soluble salt of a first metal and a water soluble sulfide or selenide in an aqueous solution to form a first reaction product
Implementation Method 2
adding an excess amount of a water soluble salt of a second metal to form an outer region
Implementation Method 3
When light impinges on the QDs, electrons in the valence band are excited to the conduction band, forming short-lived (nanoseconds) electron-hole pairs called excitons that emit photons of a specific wavelength when the electron-hole pairs eventually recombine
Data Source
AI summary
A novel quantum dot containing two different metals at non-toxic levels which is capable of narrow bandwidth near infrared emissions at wavelengths of 600-1100 nm. The quantum dot is fabricated via an aqueous method which forms a structure having an inner region of one composition and an outer region of a different composition, wherein the inner region contains at least a first metal and the outer region contains at least a second metal. The quantum dots may be enabled for bioconjugation and may be used in a method for tissue imaging and analyte detection.